These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intensive lipid-lowering therapy for patients with aortic stenosis. Pedersen TR Am J Cardiol; 2008 Dec; 102(11):1571-6. PubMed ID: 19026317 [TBL] [Abstract][Full Text] [Related]
3. Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study). Gerdts E; Rossebø AB; Pedersen TR; Boman K; Brudi P; Chambers JB; Egstrup K; Gohlke-Bärwolf C; Holme I; Kesäniemi YA; Malbecq W; Nienaber C; Ray S; Skjærpe T; Wachtell K; Willenheimer R Am J Cardiol; 2010 Dec; 106(11):1634-9. PubMed ID: 21094366 [TBL] [Abstract][Full Text] [Related]
4. Lipid lowering on progression of mild to moderate aortic stenosis: meta-analysis of the randomized placebo-controlled clinical trials on 2344 patients. Teo KK; Corsi DJ; Tam JW; Dumesnil JG; Chan KL Can J Cardiol; 2011; 27(6):800-8. PubMed ID: 21742465 [TBL] [Abstract][Full Text] [Related]
5. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Rossebø AB; Pedersen TR; Allen C; Boman K; Chambers J; Egstrup K; Gerdts E; Gohlke-Bärwolf C; Holme I; Kesäniemi VA; Malbecq W; Nienaber C; Ray S; Skjaerpe T; Wachtell K; Willenheimer R Am J Cardiol; 2007 Apr; 99(7):970-3. PubMed ID: 17398194 [TBL] [Abstract][Full Text] [Related]
6. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Chan KL; Teo K; Dumesnil JG; Ni A; Tam J; Circulation; 2010 Jan; 121(2):306-14. PubMed ID: 20048204 [TBL] [Abstract][Full Text] [Related]
7. Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial. Chan KL; Teo K; Tam J; Dumesnil JG; Am Heart J; 2007 Jun; 153(6):925-31. PubMed ID: 17540192 [TBL] [Abstract][Full Text] [Related]
8. Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study). Greve AM; Bang CN; Boman K; Egstrup K; Forman JL; Kesäniemi YA; Ray S; Pedersen TR; Best P; Rajamannan NM; Wachtell K Am J Cardiol; 2018 Mar; 121(6):739-745. PubMed ID: 29361285 [TBL] [Abstract][Full Text] [Related]
9. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. Bellamy MF; Pellikka PA; Klarich KW; Tajik AJ; Enriquez-Sarano M J Am Coll Cardiol; 2002 Nov; 40(10):1723-30. PubMed ID: 12446053 [TBL] [Abstract][Full Text] [Related]
10. [Can we prevent the progression of aortic valve sclerosis and stenosis? The need for a prospective, randomized trial]. Scardi S; Cherubini A Ital Heart J Suppl; 2005 Jul; 6(7):403-12. PubMed ID: 16082823 [TBL] [Abstract][Full Text] [Related]
16. What is the ultimate test that lowering lipoprotein(a) is beneficial for cardiovascular disease and aortic stenosis? Hung MY; Tsimikas S Curr Opin Lipidol; 2014 Dec; 25(6):423-30. PubMed ID: 25340480 [TBL] [Abstract][Full Text] [Related]
17. Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study). Bang CN; Greve AM; La Cour M; Boman K; Gohlke-Bärwolf C; Ray S; Pedersen T; Rossebø A; Okin PM; Devereux RB; Wachtell K Am J Cardiol; 2015 Dec; 116(12):1840-4. PubMed ID: 26602073 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. Cowell SJ; Newby DE; Prescott RJ; Bloomfield P; Reid J; Northridge DB; Boon NA; N Engl J Med; 2005 Jun; 352(23):2389-97. PubMed ID: 15944423 [TBL] [Abstract][Full Text] [Related]